• Aucun résultat trouvé

Kinetics of Hepatitis B Core–Related Antigen and Anti–Hepatitis B Core Antibody and Their Association With Serological Response in Human Immunodeficiency Virus–Hepatitis B Coinfection

N/A
N/A
Protected

Academic year: 2021

Partager "Kinetics of Hepatitis B Core–Related Antigen and Anti–Hepatitis B Core Antibody and Their Association With Serological Response in Human Immunodeficiency Virus–Hepatitis B Coinfection"

Copied!
41
0
0

Texte intégral

Loading

Figure

Table 1. Baseline characteristics of patients treated with tenofovir  HBeAg status  p aHBeAg-positive  (n = 95)  HBeAg-negative (n = 63)  Demographics       Male sex b 89 (93.7)  44 (69.8)       <0.001       Age (years) c 40.3 (35.0-46.7)  41.6 (37.2-49
Table 2. Baseline determinants of hepatitis B core-related antigen and anti-hepatitis B core antibody
Table 3. Kinetics of hepatitis core-related antigen and anti-hepatitis B core antibody during follow-up
Table 4 – Factors associated to HBeAg-seroclearance during follow-up
+2

Références

Documents relatifs

The number of samples correctly identified in the low titre performance panel was determined by comparison with the HBsAg status assigned (expected results) following

The number of samples correctly identified in the low titre performance panel was determined by comparison with the HBsAg status assigned (expected results) following interpretation

Over a 6-month period in 2007/08 all samples from a blood bank in Alexandria, Egypt (n = 3420) were tested for hepatitis B surface antigen (HBsAg) and anti-hepatitis C virus

In order to better understand the balance between replication and the immune response against hepatitis B virus (HBV), the viral kinetics in 50 HBeAg-negative

A third panel (panel 3) comprised 23 blood donor samples from the INTS: 4 samples tested initially positive with the PRISM HBsAg 5.0 assay (Abbott Diagnostics, Rungis, France) at

The resulting humanized antibody (HzKR127-3.2) exhibited 2.5-fold higher affinity for the preS1 antigen and enhanced virus- neutralizing activity against both adr and ayw

Con- tribution of quantitative viral markers to document hepatitis B virus compartmentalization in cere- brospinal fluid during hepatitis B with neuropathies...

The cells were incubated with serially diluted human IgG1 (IgG1, Kappa from human myeloma plasma, Sigma-Aldrich I5154) or secreted recombinant monoclonal human antibodies